Endothelial progenitor cells in cardiovascular diseases

Cardiovascular diseases (CVDs) are the leading cause of death in both developed and developing countries. Endothelial progenitor cells (EPCs) are derived from hematopoietic stem cells with powerful function of angiogenesis. There are many studies on the relation between coronary heart disease and ci...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Yumin, Zhang, Chanjuan, Zhang, Gaoxing, Tao, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880702/
https://www.ncbi.nlm.nih.gov/pubmed/31942498
http://dx.doi.org/10.1002/agm2.12041
_version_ 1783473814983671808
author Qiu, Yumin
Zhang, Chanjuan
Zhang, Gaoxing
Tao, Jun
author_facet Qiu, Yumin
Zhang, Chanjuan
Zhang, Gaoxing
Tao, Jun
author_sort Qiu, Yumin
collection PubMed
description Cardiovascular diseases (CVDs) are the leading cause of death in both developed and developing countries. Endothelial progenitor cells (EPCs) are derived from hematopoietic stem cells with powerful function of angiogenesis. There are many studies on the relation between coronary heart disease and circulating EPCs. In this review, we discuss biological characteristics of endothelial progenitor cells, some influencing factors of the number and function of EPCs, and the role of EPCs in the treatment of cardiovascular disease. At last, we bring some perspectives on the future of endothelial progenitor cell therapy.
format Online
Article
Text
id pubmed-6880702
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-68807022020-01-15 Endothelial progenitor cells in cardiovascular diseases Qiu, Yumin Zhang, Chanjuan Zhang, Gaoxing Tao, Jun Aging Med (Milton) Review Articles Cardiovascular diseases (CVDs) are the leading cause of death in both developed and developing countries. Endothelial progenitor cells (EPCs) are derived from hematopoietic stem cells with powerful function of angiogenesis. There are many studies on the relation between coronary heart disease and circulating EPCs. In this review, we discuss biological characteristics of endothelial progenitor cells, some influencing factors of the number and function of EPCs, and the role of EPCs in the treatment of cardiovascular disease. At last, we bring some perspectives on the future of endothelial progenitor cell therapy. John Wiley and Sons Inc. 2018-09-19 /pmc/articles/PMC6880702/ /pubmed/31942498 http://dx.doi.org/10.1002/agm2.12041 Text en © 2018 The Authors. Aging Medicine published by Beijing Hospital and John Wiley & Sons Australia, Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Review Articles
Qiu, Yumin
Zhang, Chanjuan
Zhang, Gaoxing
Tao, Jun
Endothelial progenitor cells in cardiovascular diseases
title Endothelial progenitor cells in cardiovascular diseases
title_full Endothelial progenitor cells in cardiovascular diseases
title_fullStr Endothelial progenitor cells in cardiovascular diseases
title_full_unstemmed Endothelial progenitor cells in cardiovascular diseases
title_short Endothelial progenitor cells in cardiovascular diseases
title_sort endothelial progenitor cells in cardiovascular diseases
topic Review Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880702/
https://www.ncbi.nlm.nih.gov/pubmed/31942498
http://dx.doi.org/10.1002/agm2.12041
work_keys_str_mv AT qiuyumin endothelialprogenitorcellsincardiovasculardiseases
AT zhangchanjuan endothelialprogenitorcellsincardiovasculardiseases
AT zhanggaoxing endothelialprogenitorcellsincardiovasculardiseases
AT taojun endothelialprogenitorcellsincardiovasculardiseases

Ejemplares similares